ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2085

DC-STAMP Regulates Osteoclastogenesis through the Ca2+ /NFATc1 Axis

Yahui Grace Chiu1, Dongge Li2, Yue-Xin Xu3, Tzong-Ren Sheu4, Minsoo Kim5 and Christopher T. Ritchlin6, 1Allergy, Immunology, and Rheumatology, University of Rochester, Rochester, NY, 2Allergy, Immunology and Rheumatology, University of Rochester, Rochester, NY, 3Microbiology & Immunology, University of Rochester, Rochester, NY, 4Center for Musculoskeletal Research, University of Rochester, Rochester, NY, 5Microbiology and Immunology, University of Rochester, Rochester, NY, 6Allergy, Immunology and Rheumatololgy Division, University of Rochester Medical Center, Rochester, NY

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Calcium, osteoclastogenesis, osteoclasts and signal transduction, RANK/RANKL pathway

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 9, 2015

Title: Biology and Pathology of Bone and Joint: Bone Remodeling

Session Type: ACR Concurrent Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose:

Osteoclasts (OC) are the only cell type known to erode bone. Many bone diseases including osteoporosis and arthritis are caused by excessive OC activity. The molecular mechanisms underlying cell-cell fusion, a key step in osteoclastogenesis (OCgenesis), are not well understood. Our studies focused on DC-STAMP (Dendritic Cell-Specific Transmembrane Protein), a 7-pass transmembrane protein which is expressed on the cell surface of OC precursors (OCPs) and is essential for OCgenesis. DC-STAMP knock-out (KO) mice form only mono-nucleated OC, and manifest mild osteopetrosis due to the absence of functional polykaryon OC. Previously, we identified an Immunoreceptor Tyrosine-based Inhibitory Motif (ITIM) on the cytoplasmic tail of DC-STAMP. By engineering a DC-STAMP:rhodopsin photactivatable chimeric molecule that can be activated by light, we demonstrated that the ITIM is a functional motif that alters intracellular Ca+2flux, suggesting the potential role of DC-STAMP in signaling. Herein, we further examined the effect of ITIM deletion on bone erosion, cell mobility, and NFATc1 nuclear translocation.

Methods:

The wild-type (WT) and ITIM-deleted (TD) versions of DC-STAMP were tagged with GFP, and introduced into DC-STAMP-/- cells isolated from the DC-STAMP KO mice. DC-STAMP-/- cells which overexpress WT- or TD- DC-STAMP were tested for complementation to OC-forming deficiency by in vitro culture, bone erosion activity by bone wafer assay, cell surface distribution by confocal microscopy, and cell mobility by the scanning electron microscopy (SEM). The dynamic changes of NFATc1 protein after introduction of the WT DC-STAMP into DC-STAMP-/- cells were examined by Western blotting.

Results:

Deletion of the DC-STAMP ITIM was associated with decreased OCgenesis and altered downstream signaling as summarized by the following key observations. (1) Complementation: The OC-forming deficiency of DC-STAMP-/- cells was complemented when cells were infected with WT- but not TD- DC-STAMP; (2) Cell-cell fusion: Most of the TD-DC-STAMP-expressing cells were mononuclear, whereas a minority fused twice with 3 maximal nuclei per cell. As expected, TD cells showed smaller cell volumes than WT-DC-STAMP expressing cells due to the limited frequency of cell-cell fusion; (3) Bone erosion: TD-DC-STAMP-expressing cells showed decreased bone erosion activity as evidenced by smaller and shallower erosion pits (7.2 & 1.5 mm2/pit area for WT & TD, respectively), which is associated with a reduced cell mobility revealed by SEM; (4) NFATc1 nuclear translocation: in contrast to WT-DC-STAMP, the NFATc1 proteins in TD-DC-STAMP-expressing cells failed to translocate to the nuclei.

Conclusion:

The ITIM on DC-STAMP is a functional motif that regulates OCgenesis through the Ca2+/NFATc1 axis. Deletion of ITIM on DC-STAMP resulted in decreased bone erosion activity, impaired osteoclast mobility, and diminished nuclear translocation of NFATc1. This is the first demonstration that DC-STAMP regulates the translocation of NFATc1, a master transcription factor of OCgenesis. Targeted inhibition of the ITIM on DC-STAMP may prove an effective strategy to prevent pathologic bone in inflammatory and metabolic bone disorders.


Disclosure: Y. G. Chiu, None; D. Li, None; Y. X. Xu, None; T. R. Sheu, None; M. Kim, None; C. T. Ritchlin, AbbVie, 5,Amgen, 5,Novartis Pharmaceutical Corporation, 5,Eli Lilly and Company, 5,Boehringer Ingelheim, 5,Sanofi-Aventis Pharmaceutical, 5,Amgen, 2,AbbVie, 2,UCB Pharma, 2.

To cite this abstract in AMA style:

Chiu YG, Li D, Xu YX, Sheu TR, Kim M, Ritchlin CT. DC-STAMP Regulates Osteoclastogenesis through the Ca2+ /NFATc1 Axis [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/dc-stamp-regulates-osteoclastogenesis-through-the-ca2-nfatc1-axis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/dc-stamp-regulates-osteoclastogenesis-through-the-ca2-nfatc1-axis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology